Álvaro Juárez Soto

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer

Kim N., Neeraj Agarwal, Anders Bjartell et al. · New England Journal of Medicine · 2019 · 1.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study

Neeraj Agarwal, Kelly McQuarrie, Anders Bjartell et al. · The Lancet Oncology · 2019 · 116 citations · Full text

Pharmacy, Oncology, Urology +16

Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer

S. Chowdhury, Anders Bjartell, Neeraj Agarwal et al. · Annals of Oncology · 2023 · 113 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN study

Axel S. Merseburger, Neeraj Agarwal, Amitabha Bhaumik et al. · European Journal of Cancer · 2023 · 28 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy

Axel S. Merseburger, Neeraj Agarwal, Anders Bjartell et al. · British Journal of Urology · 2024 · 22 citations · Full text

Medicine, Oncology, Urology +17